Viewing Study NCT00879333

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-02-10 @ 9:32 PM
Study NCT ID: NCT00879333
Status: COMPLETED
Last Update Posted: 2015-11-03
First Post: 2009-04-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastric cancer, View
None advanced gastric cancer, View
None stomach neoplasm, View
None stomach disease, View
None adenocarcinoma of stomach, View
None GI neoplasm View